Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2003
10/29/2003EP1356814A1 Pharmaceutical emulsion preparation
10/29/2003EP1356812A1 Medicines for treatment and prevention of neurogenic pain
10/29/2003EP1356288A1 Screening assay for cotranslational translocation interfering compounds
10/29/2003EP1356284A2 Schizophrenia related genes
10/29/2003EP1356278A2 Methods and compositions for the identification and treatment of neurodegenerative disorders
10/29/2003EP1356058A2 Crystal structure of dimethylarginine dimethylaminohydrolase and arginine deiminase
10/29/2003EP1356047A2 Human proteins, polynucleotides encoding them and methods of using the same
10/29/2003EP1356046A2 Cytokine receptor zcytor19
10/29/2003EP1356043A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
10/29/2003EP1356042A2 Carbohydrate-associated proteins
10/29/2003EP1356039A2 Down syndrome critical region 1-like 1 proteins
10/29/2003EP1356028A2 Protein modification and maintenance molecules
10/29/2003EP1356024A2 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods
10/29/2003EP1355949A1 Conformationally abnormal forms of tau proteins and specific antibodies thereto
10/29/2003EP1355943A2 Neurotransmitter transporters
10/29/2003EP1355940A2 Urotensin-ii agonists and antagonists
10/29/2003EP1355939A2 Interferons, uses and compositions related thereto
10/29/2003EP1355936A2 Polymer conjugates of neublastin and methods of using same
10/29/2003EP1355935A2 Secreted proteins
10/29/2003EP1355922A2 Stress proteins and peptides and methods of use thereof
10/29/2003EP1355909A2 Dihydropyrazolopyridine compounds and pharmaceutical use thereof
10/29/2003EP1355907A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1355905A1 Pyrazole compounds useful as protein kinase inhibitors
10/29/2003EP1355904A2 Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands
10/29/2003EP1355902A1 Sulfonamide compounds, their preparation and use
10/29/2003EP1355900A2 Heterocyclylalkylindole or -azaindole compounds as 5-hydroxytryptamine-6 ligands
10/29/2003EP1355893A2 Antiangiogenic compounds and an assay for inhibitors of cell invasion
10/29/2003EP1355888A1 Quinazolinone derivatives
10/29/2003EP1355885A1 Pyridine derivatives useful as cyclooxygenase inhibitor
10/29/2003EP1355884A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1355881A2 An improved process for preparing pure ondansetron hydrochloride dihydrate
10/29/2003EP1355875A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/29/2003EP1355669A2 Augmented cognitive training
10/29/2003EP1355666A2 Use of rgm and its modulators
10/29/2003EP1355654A1 Lower alcohol-insoluble extract of hovenia dulcis var. koreana nakai, a polysaccharide isolated therefrom and an antihepatotoxic composition containing same
10/29/2003EP1355646A1 Muscarinic receptor agonists
10/29/2003EP1355645A2 Method for treating fibrotic diseases or other indications iiic
10/29/2003EP1355643A2 Epoxyvibsanin b
10/29/2003EP1355642A2 INHIBITION OF NF-(k)B BY TRITERPENE COMPOSITIONS
10/29/2003EP1355640A1 Use of non-competitive and selective glur5 antagonists as glutamate receptor modulating compounds
10/29/2003EP1355639A2 Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists
10/29/2003EP1355638A2 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
10/29/2003EP1355633A1 New film coating
10/29/2003EP1355631A2 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor
10/29/2003EP1355530A2 Method for the detection of prions in a sample
10/29/2003EP1257527B1 (2s)-aminoindan derivatives, a process for their preparation and their use as selective dopamine d3 ligands
10/29/2003EP1251853B1 Transdermal therapeutic system for the administration of zaleplon
10/29/2003EP1235787B1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
10/29/2003EP1212324B1 Imidazo-triazine derivatives as ligands for gaba receptors
10/29/2003EP1204663B1 Novel spiro compounds with neuropeptide y antagonistic activity
10/29/2003EP1204429B1 Sustained release formulation of a peptide
10/29/2003EP1169316B9 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
10/29/2003EP1147112B1 Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
10/29/2003EP1107940B1 Vitamin d3 mimics
10/29/2003EP1077935B1 Phenylsulfonamide-phenylethylamines useful as dopamine receptors
10/29/2003EP1056705B1 Stable hyperforin salts, method for producing same and their use in the treatment of alzheimer's disease
10/29/2003EP1009804B1 Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof
10/29/2003EP0946162B1 Use of p-aminophenol derivatives for the preparation of pharmaceutical compositions useful in the treatment of neurodegenerative diseases
10/29/2003EP0779281B1 Isoxazoles
10/29/2003CN1452630A Substd. sapogenins and their use
10/29/2003CN1452623A 4-phenyl substd. tetrahydroisoquinolines and therapeutic use thereof
10/29/2003CN1452622A Piperzine devivs.
10/29/2003CN1452613A Amorphous torasemide modification
10/29/2003CN1452610A Compound, compositions and methods for preventing neurodegeneration in acute and chronic injuries in central nervous system
10/29/2003CN1452497A Combinations of SSRI and estrogenic agents
10/29/2003CN1452496A Use of strains of parapox ovis virus against organ fibrosis
10/29/2003CN1452492A Neuroprotective peptides
10/29/2003CN1452490A Composition and method for intervening neuronal death using sulfasalazine
10/29/2003CN1452489A Praziquantel composition for treating diseases due to sarcocystis, neospora, toxoplasma and isospora
10/29/2003CN1452486A Pharmaceutical composition and use method
10/29/2003CN1452483A IL-8 receptor antagonists
10/29/2003CN1451747A Medusa cystatin gene, and expression and use thereof
10/29/2003CN1451739A Sedative kidney-reinforcing medicinal liquor
10/29/2003CN1451411A formulation of ÔÇ£GuilujiannaoanshenÔÇØ tablet medicinal preparation and preparing process thereof
10/29/2003CN1451396A Dose of sobriety and producing process
10/29/2003CN1451384A Use of timosaponin for preparing medicine for preventing and treating brain apoplexy
10/29/2003CN1451382A Medicine for treating senile dementia and preparing process thereof
10/29/2003CN1451315A Alpha wave emitting enhancing agent, agent capable of leading relaxation state and diet contg. above-mentioned agents
10/29/2003CN1125821C Compounds derived from thophene and benzothiophene, and related utilisation and compsn.
10/29/2003CN1125818C Amino acid derivatives of substituted quinexaline 2,3-dione derivatives as glutamate receptor antagonists
10/29/2003CN1125812C Novel modifications to 2-amino-4 (4-fluorobenzylamino)-1-ethoxy. carbonyl-aminobenzene and processes for preparing said compound
10/29/2003CN1125807C Excitatory amino acid receptor modulators
10/29/2003CN1125651C Novel synergistic compositions containing aromatic compounds and terpenoids present in alpinia galanga
10/29/2003CN1125648C Patch for giving out smoking and its preparing process
10/29/2003CN1125639C Paroxetine Compsns
10/29/2003CN1125637C Application of 5,3',5'-trihydroxy-7-methoxyl dihydroflavone in preparing medicine
10/28/2003US6639111 Bind on EP4 subtype receptor selectively and binds on the other subtype receptors weakly; side-effect reduction; autoimmune diseases; asthma; bone disorders; degenerative nerve diseases; sleeping disorders; anticoagulants
10/28/2003US6638981 Topical compositions and methods for treating pain
10/28/2003US6638976 3-benzoylphenylacetic acids and derivatives, including nepafenac, to treat neurodegenerative retinal disorders
10/28/2003US6638972 Chroman and benzofuran derivatives as 5-hydroxytryptamine-6 ligands
10/28/2003US6638967 Pyrrole, furan, thiofuran and phenyl derivatives; inhibition of histamine H3 receptor activity; for example, 1-((4-(4-Pyrrolidin-1-ylmethyl-phenyl)-thien-2-yl)methyl)-pyrrolidine
10/28/2003US6638962 Cycloheptene compounds
10/28/2003US6638953 Indole derivatives as 5-HT receptor antagonist
10/28/2003US6638947 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
10/28/2003US6638946 Substituted pyridine or piperidine compounds
10/28/2003US6638942 Spiro-indolines as Y5 receptor antagonists
10/28/2003US6638936 Treatment of obesity in mammals, comprising administering to mammal in need of such treatment, treatment of obsessive compulsive disorder in mammals, comprising administering to a mammal treatment of depression in mammals
10/28/2003US6638934 2,3,4,4a,5,6-hexahydro-1H-pyrazino(1,2-a)quinoxaline derivatives; treating depression, schizophrenia; (5-hydroxytryptamine=5HT) 5HT2a antagonist or a 5HT2c agonist
10/28/2003US6638933 Bicyclic imidazo-3-yl-amine derivatives
10/28/2003US6638926 Pyrazole compounds useful as protein kinase inhibitors
1 ... 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 ... 1833